Teva Pharmaceutical Industries Limited (TEVA)
-NYSE 39.34 
0.15(0.38%) 4:02PM EDT
| Prev Close: | 39.49 |
|---|
| Open: | 39.50 |
|---|
| Bid: | 38.82 x 200 |
|---|
| Ask: | 40.35 x 100 |
|---|
| 1y Target Est: | 44.48 |
|---|
| Beta: | 0.75 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 38.89 - 39.55 |
|---|
| 52wk Range: | 36.63 - 42.83 |
|---|
| Volume: | 3,354,591 |
|---|
| Avg Vol (3m): | 4,114,400 |
|---|
| Market Cap: | 33.52B |
|---|
| P/E (ttm): | 19.64 |
|---|
| EPS (ttm): | 2.00 |
|---|
| Div & Yield: | 1.09 (2.70%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Will Twice Be Nice For The Israel ETF?ETF Trends(Thu, May 23)
- 4 Big Drug Companies With Big Juicy Yieldsat Motley Fool(Wed, May 22)
- Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industryat Seeking Alpha(Wed, May 22)
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA)at TheStreet(Tue, May 21)
- A New Drug Sales Modelat Motley Fool(Mon, May 20)
- Ireland Welcomes Watson Pharmaceuticals, an American Successat TheStreet(Mon, May 20)
- Is There a Bubble Brewing?at Motley Fool(Mon, May 20)
- Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pillat Seeking Alpha(Mon, May 20)
- Israel seeks to rein in company tax breaksat Reuters(Mon, May 20)
- A Broad Look At Teva's Pipelineat Seeking Alpha(Mon, May 20)
- SmithOnStocks Opines On Stocks: May 19th Editionat Seeking Alpha(Sun, May 19)
- Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Startedat Motley Fool(Sun, May 19)
- Statin Users May Have a Reason to Rejoice After This Dataat Motley Fool(Sun, May 19)
- Good News For Health Care Stocks Part 2at Motley Fool(Fri, May 17)
- Billionaire Frost Props Up Prolor Bid With Stock Buysat Bloomberg(Thu, May 16)
Key Statistics
| Forward P/E (1 yr): | 7.23 |
|---|
| P/S (ttm): | 1.67 |
|---|
| Ex-Dividend Date: | 16-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.02 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.20 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 1.11 |
|---|
Business Summary
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as ste...
View More